Cargando…
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring
A new family of anticancer compounds has been derived from oxaliplatin by inserting a double-bond between carbons 4 and 5 of the 1,2-diaminocyclohexane ring. Testing against a panel of human tumour cell lines including cervical (A431), ovarian (2008), and colon carcinomas (HCT-15 and LoVo), and two...
Autores principales: | Papadia, Paride, Gandin, Valentina, Barbanente, Alessandra, Ruello, Alessandro G., Marzano, Cristina, Micoli, Katia, Hoeschele, James D., Natile, Giovanni, Margiotta, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072990/ https://www.ncbi.nlm.nih.gov/pubmed/35529760 http://dx.doi.org/10.1039/c9ra07760j |
Ejemplares similares
-
Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance
por: Papadia, Paride, et al.
Publicado: (2020) -
New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity
por: Barbanente, Alessandra, et al.
Publicado: (2021) -
Cisplatin, Oxaliplatin, and Kiteplatin Subcellular Effects Compared in a Plant Model
por: Papadia, Paride, et al.
Publicado: (2017) -
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration
por: Barbanente, Alessandra, et al.
Publicado: (2022) -
Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions
por: Savino, Salvatore, et al.
Publicado: (2018)